Economic Models of Colorectal Cancer Screening in Average-Risk Adults

Michael Pignone, Louise Russell and Judith Wagner, Editors, Institute of Medicine and National Research Council

• 1 Front Matter; 2 Workshop Summary; 3 References; 4 Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults; 5 Appendix B Workshop Participants; 6 Appendix C Workshop Speaker and Staff Biographies; 7 Appendix D Overview of Harvard Model--Karen M. Kuntz, ScD; 8 Appendix E Description of the Laudabaum Colorectal Cancer Screening Model--Uri Ladabaum, M.D., M.S; 9 Appendix F MISCAN-colon: An Overview--Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema; 10 Appendix G The Vanderbilt Colorectal Cancer Model--R.M. Ness, R.W. Klein, R.S. Dittus; 11 Appendix H Overview of the Vijan Colorectal Cancer Screening Model--Sandeep Vijan, M.D., M.S; 12 Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D.,; 13 Appendix J Recent Findings on Test Performance--Brian P. Mulhall, M.D., M.P.H; 14 Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening--Martin L. Brown, Ph.D; 15 Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D; 16 Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries--Todd Anderson, M.S; 17 Appendix N Preliminary Results from CDC; 18 Appendix O Colorectal Cancer Surveillance Testing After Polypectomy--Deborah Schrag, M.D., M.P.H; 19 Appendix P Natural History of Colorectal Adenomas and Cancer--T. R. Levin, M.D; 20 Appendix Q CISNET-Cancer Intervention and Surveillance--Eric J. (Rocky) Feuer, Ph.D